MedDataX Logo

Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Chronic Neuropathic Pain.

NCT ID: NCT00141362

Last Updated: 2007-01-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

325 participants

Study Classification

INTERVENTIONAL

Study Start Date

2001-10-31

Study Completion Date

2005-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluate long-term safety and efficacy of pregabalin in patients with chronic neuropathic pain.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Postherpetic Neuralgia.

NCT00150436

Neuralgia
COMPLETED PHASE3

Safety and Efficacy of Pregabalin in Patients With Diabetic Peripheral Neuropathy.

NCT00141401

Diabetic Neuropathy, Painful
COMPLETED PHASE3

To Evaluate the Safety and Efficacy of Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy.

NCT00150423

Diabetic Neuropathy, Painful
COMPLETED PHASE3

Pilot Study Of Pregabalin And Prediction Of Treatment Response In Patients With Postherpetic Neuralgia

NCT01603394

Postherpetic Neuralgia
TERMINATED PHASE4

To Evaluate Long-Term Safety and Efficacy of Pregabalin in the Treatment of Neuropathic Pain After Spinal Cord Injury.

NCT00141375

Neuropathic Pain
COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pregabalin

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Must have received study medication under double-blind conditions.

Exclusion Criteria

* Patients cannot participate if they experienced a serious adverse event during the previous double-blind BID study which was determined to be related to the study medication.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pfizer

INDUSTRY

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pfizer CT.gov Call Center

Role: STUDY_DIRECTOR

Pfizer

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1008-000-166

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Postherpetic Neuralgia
NCT00424372 COMPLETED PHASE3
Pregabalin in CIPN
NCT02394951 COMPLETED NA
Pregabalin for Treatment of Patients With Postherpetic Neuralgia (PHN)
NCT01455428 COMPLETED PHASE4
Placebo-controlled Safety and Efficacy Study of Pregabalin in Subjects With Post-traumatic Peripheral Neuropathic Pain
NCT01701362 COMPLETED PHASE3
Pregabalin vs Placebo in Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
NCT00143156 COMPLETED PHASE3
A Study to Assess the Efficacy, Safety and Tolerability of Pregabalin in Patients With Symptoms of Neuropathic Pain
NCT00301223 COMPLETED PHASE3
Pregabalin Peripheral Neuropathic Pain Study
NCT00141219 COMPLETED PHASE3
The Efficacy and Safety of Pregabalin Release Tablets for the Treatment of Fibromyalgia
NCT02868814 UNKNOWN PHASE3
Primary Care Identification Of Patients With Chronic Neuropathic Low Back Pain Study
NCT01298466 WITHDRAWN PHASE4
Study To Assess The Reproducibility And Sensitivity Of Quantitative Sensory Testing In Patients With Neuropathic Pain
NCT01117766 COMPLETED NA
Neuropathic Pain Syndrome Patient Study (MK-0000-072)
NCT00570310 COMPLETED PHASE1
A Study For Pregabalin In Patients With Fibromyalgia
NCT01387607 COMPLETED PHASE3
A 13-Week, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Postherpetic Neuralgia
NCT00394901 COMPLETED PHASE3
A Study of the Efficacy and Safety of Pregabalin for the Treatment of Diabetic Peripheral Neuropathy or Postherpetic Neuralgia
NCT00629681 COMPLETED PHASE4
A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Pain Associated With Diabetic Peripheral Neuropathy
NCT00553280 COMPLETED PHASE3
A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin In Patients With Fibromyalgia
NCT00830128 COMPLETED PHASE3
Determine Long-Term Safety and Tolerability of Pregabalin in Patients With Anxiety Disorders.
NCT00150449 COMPLETED PHASE3
Efficacy Study Measuring the Impact of Pregabalin on Peripheral Neuropathic Pain.
NCT00219544 COMPLETED PHASE3
A Post Marketing Surveillance Study On Pregabalin (Lyrica) On Efficacy, Safety And Tolerability Of Pregabalin
NCT00892008 COMPLETED
A Study to Evaluate the Efficacy and Safety of Pregabalin (Lyrica) for the Treatment of Nerve Pain
NCT00631943 COMPLETED PHASE3
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
NCT01455415 COMPLETED PHASE3
Trial of Efficacy and Safety of Pregabalin in Subjects With Neuropathic Pain Associated With Lumbo-Sacral Radiculopathy
NCT00159705 COMPLETED PHASE3
A Randomized Double-Blind Study Testing the Effects of Pregabalin on Diabetic Neuropathy
NCT00573261 COMPLETED PHASE4
Pregabalin in Preventing Acute Pain Syndrome in Patients Receiving Paclitaxel
NCT01637077 COMPLETED PHASE2
Study of Pregabalin Therapy for Pain Relief in Subjects With Post-Herpetic Neuralgia
NCT00159666 COMPLETED PHASE4